GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Human Metabolome Technologies Inc (TSE:6090) » Definitions » Gross Margin %

Human Metabolome Technologies (TSE:6090) Gross Margin % : 69.37% (As of Mar. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Human Metabolome Technologies Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Human Metabolome Technologies's Gross Profit for the three months ended in Mar. 2024 was 円335 Mil. Human Metabolome Technologies's Revenue for the three months ended in Mar. 2024 was 円483 Mil. Therefore, Human Metabolome Technologies's Gross Margin % for the quarter that ended in Mar. 2024 was 69.37%.

Warning Sign:

Human Metabolome Technologies Inc gross margin has been in long-term decline. The average rate of decline per year is -2.7%.


The historical rank and industry rank for Human Metabolome Technologies's Gross Margin % or its related term are showing as below:

TSE:6090' s Gross Margin % Range Over the Past 10 Years
Min: 59.23   Med: 70.51   Max: 79.75
Current: 63.89


During the past 10 years, the highest Gross Margin % of Human Metabolome Technologies was 79.75%. The lowest was 59.23%. And the median was 70.51%.

TSE:6090's Gross Margin % is ranked better than
73.33% of 210 companies
in the Medical Diagnostics & Research industry
Industry Median: 46.095 vs TSE:6090: 63.89

Human Metabolome Technologies had a gross margin of 69.37% for the quarter that ended in Mar. 2024 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Human Metabolome Technologies was -2.70% per year.


Human Metabolome Technologies Gross Margin % Historical Data

The historical data trend for Human Metabolome Technologies's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Human Metabolome Technologies Gross Margin % Chart

Human Metabolome Technologies Annual Data
Trend Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Jun20 Jun21 Jun22
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 79.14 69.31 76.60 71.71 68.67

Human Metabolome Technologies Quarterly Data
Mar19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 72.83 55.96 51.92 68.78 69.37

Competitive Comparison of Human Metabolome Technologies's Gross Margin %

For the Diagnostics & Research subindustry, Human Metabolome Technologies's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Human Metabolome Technologies's Gross Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Human Metabolome Technologies's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Human Metabolome Technologies's Gross Margin % falls into.



Human Metabolome Technologies Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Human Metabolome Technologies's Gross Margin for the fiscal year that ended in Jun. 2022 is calculated as

Gross Margin % (A: Jun. 2022 )=Gross Profit (A: Jun. 2022 ) / Revenue (A: Jun. 2022 )
=840 / 1223.281
=(Revenue - Cost of Goods Sold) / Revenue
=(1223.281 - 383.277) / 1223.281
=68.67 %

Human Metabolome Technologies's Gross Margin for the quarter that ended in Mar. 2024 is calculated as


Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=334.8 / 482.655
=(Revenue - Cost of Goods Sold) / Revenue
=(482.655 - 147.853) / 482.655
=69.37 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Human Metabolome Technologies  (TSE:6090) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Human Metabolome Technologies had a gross margin of 69.37% for the quarter that ended in Mar. 2024 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Human Metabolome Technologies Gross Margin % Related Terms

Thank you for viewing the detailed overview of Human Metabolome Technologies's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Human Metabolome Technologies (TSE:6090) Business Description

Traded in Other Exchanges
N/A
Address
Yamagata Prefecture Kakuganji Water 246-2, Tsuruoka, JPN, 997-0052
Human Metabolome Technologies, Inc is involved in the search and diagnosis of biomarkers and commercialization in the field of drug development.

Human Metabolome Technologies (TSE:6090) Headlines

No Headlines